Clinical Trial Update: The Separate and Combined Effects of Vivitrol and Opiate Abstinence Reinforcement in the Treatment of Opioid Dependence [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the separate and combined effects of Vivitrol (naltrexone extended-release) and opiate abstinence reinforcement in opioid dependence; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Dependence

Drugs mentioned

• Opiate Abstinence Reinforcement
• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: Johns Hopkins University | Conditions: Opioid Dependence | Phase 2 | Status: COMPLETED | Results posted: 2018-02-13